Dec 20, 2024 · Acute myelogenous leukemia, also called AML, is a cancer of the blood and bone marrow. Bone marrow is the soft matter inside bones where blood cells are made. The word …

Mar 21, 2023 · What is acute myeloid leukemia (AML)? Acute myeloid leukemia (AML) is a rare cancer that affects your bone marrow and blood. It typically happens when certain genes or …

Acute myeloid leukemia (AML) starts in the bone marrow, the soft inner part of certain bones, where new blood cells are made. Most often AML quickly moves from the bone marrow into …

Between 2017 and 2025, 12 new agents have been approved for AML in the U.S., including venetoclax (BCL2 inhibitor), gemtuzumab ozogamicin (CD33 antibody-drug conjugate), and …

Acute myeloid leukemia is a type of cancer that affects myeloid stem cells, which produce red blood cells, platelets and granulocytes, a type of white blood cell. Learn about the causes, …

Mar 14, 2025 · AML is a heterogenous group of blood cancers that result from clonal expansion of myeloid hematopoietic precursors in the bone marrow.

Dec 2, 2025 · A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute myeloid leukemia (AML) is driving better survival …

Dec 1, 2025 · Updated American Society of Hematology acute myeloid leukemia treatment guidelines highlight changing outcomes for older adults with AML.

Acute myeloid leukemia (AML) is a bone marrow stem cell cancer that is often fatal despite available treatments. Diagnosis, risk assessment, monitoring, and therapeutic management of …

Jun 18, 2024 · Most types of AML are treated with more than one chemotherapy medicine. Drugs that are targeted to specific mutations in the leukemic cells are also often used.